Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Dr. Reddy's Laboratories Ltd.

Price on BSE   12 Aug,13:40 LIVE
1,196.65
-8.35
(-0.69%)

© 2026 Rediff.com
  • Volume :
  • 85,322.00
  • Prev Close :
  • 1,205.00
  • Day's H/L (Rs.) :
  • 1,206.00 - 1,190.00
  • 52wk H/L (Rs.) :
  • 1,414.40 - 1,080.05
  • Mkt Cap (Rs. Cr) :
  • 99,884.38
Price on NSE   12 Aug,13:40 LIVE
1,196.40
-8.60
(-0.71%)

© 2026 Rediff.com
  • Volume :
  • 1,603,363.00
  • Prev Close :
  • 1,205.00
  • Day's H/L (Rs.) :
  • 1,206.80 - 1,190.00
  • 52wk H/L (Rs.) :
  • 1,414.90 - 1,101.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Indian drugmakers in no rush to shift to US despite tariff threat
Rediff.com   1 day(s) ago
Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues
Rediff.com   23 Jul 2026
Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week
Rediff.com   19 Jul 2026
Indian Pharma Bets Beyond US Generics
Rediff.com   26 Jun 2026
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
31.25
EPS (Rs.)
38.56
Sales (Rs. Cr)
5,136.60
Face Value (Rs.)
1
Net Profit Margin(%)
15.68
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
10.26

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Launches Generic Sugammadex Injection in US
Dr Reddy''s launches generic Sugammadex injection in the US, offering an affordable alternative to Bridion for reversing muscle relaxants during surgery.
Aug 04, 2026 13:33
Dr Reddy''s shares tumble 9% post-Q1 earnings, hit 52-week low
Dr Reddy''s shares plunged nearly 9% to a 52-week low after Q1 net profit fell 69.2%. Semaglutide API issues and generics revenue dip cited.
Jul 23, 2026 11:00
Dr Reddy''s CEO: US Tariffs Will Hike Drug Prices
Dr Reddy''s CEO Erez Israeli warns US tariffs on generic medicines will lead to higher drug prices. India, a major exporter, will be impacted by Trump''s plan.
Jul 22, 2026 19:03
Dr Reddy''s Q1 Profit Plunges 69.2% Amid Semaglutide Issue
Dr Reddy''s Q1 net profit fell 69.2% to Rs 434.8 cr, impacted by semaglutide ingredient provisions & North America generics dip. Revenue also declined.
Jul 22, 2026 17:19
US Tariffs on Generic Drugs: India''s Pharma Exports at Risk
GTRI warns US tariffs on generic medicines could significantly impact India''s largest pharma export market. Trump''s plan aims to reshore production, affecting Indian companies.
Jul 22, 2026 14:24

More News for Dr. Reddy's Laboratories Ltd. »

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology. Wikipedia

News for Pharmaceuticals

N Chandra to Exit Tata Sons Amid Standoff with Noel Tata
N Chandrasekaran will step down as Tata Sons chairman in 2027 after a reappointment dispute with Tata Trusts'' Noel Tata. Learn about the leadership change and succession challenges.
Aug 12, 2026 12:29
Tata Group Stocks Fall; TCS Tumbles After Chairman''s Decision
Tata Group stocks, including TCS, Tata Motors, and Titan, fell sharply after Tata Sons Chairman N Chandrasekaran announced he won''t seek reappointment.
Aug 12, 2026 12:25
Ardee Industries Shares Debut with 39% Premium
Ardee Industries shares listed with a nearly 39% premium on BSE & NSE. The IPO, subscribed 133 times, marks a strong debut for the circular economy firm.
Aug 12, 2026 11:45
N Chandrasekaran to Step Down as Tata Sons Chairman in 2027
Tata Sons Chairman N Chandrasekaran announced he won&''t seek reappointment after his term ends in Feb 2027, citing lack of unanimous board support. Succession planning begins.
Aug 12, 2026 11:40
Yulu Raises $93M Series C, Plans 2 Lakh EV Fleet Expansion
Electric mobility platform Yulu secures $93M in Series C funding to scale its EV fleet to 200,000, expand services, and prepare for public markets.
Aug 12, 2026 10:32

More News »

Top News

Ramky Infrastructure Q1 Profit Drops 47% to Rs 39 Cr
Ramky Infrastructure reports a 47.1% decline in Q1 FY27 net profit to Rs 39.3 crore, despite total income rising to Rs 543.3 crore. CEO eyes sustained growth.
Aug 12, 2026 13:30
MAN Industries Q1 Profit Doubles to Rs 61.43 Cr
MAN Industries (India) Ltd reported Q1FY27 net profit of Rs 61.43 crore, more than double year-ago. Income rose to Rs 1,064.96 crore with a Rs 3,600 crore order book.
Aug 12, 2026 13:02
Guar Seed Futures Rise on Higher Investor Bets
Guar seed futures prices increased by Rs 41 to Rs 6,251 per quintal on NCDEX due to higher investor bets, despite a fall in spot prices.
Aug 12, 2026 12:47
Guar Gum Futures Rise on Firm Demand: NCDEX Update
Guar gum futures prices rose by Rs 55 to Rs 11,978 per quintal on NCDEX. Strong speculator holdings and firm spot demand fueled the increase.
Aug 12, 2026 12:46
Coriander Futures Decline Amid Weak Spot Demand
Coriander futures prices fell by Rs 28 to Rs 16,530 per quintal on NCDEX due to weak spot demand and profit-booking by speculators.
Aug 12, 2026 12:45

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com